OptiBiotix Health PLC's (LON:OPTI) Stephen O'Hara caught up with Proactive London's Andrew Scott after announcing they've signed a one-year deal with Lebanon-based Prosperous Pharma - a pharmaceutical distributor that also supplies nutraceuticals to doctors, pharmacies and consumers.
It will have exclusive rights over OptiBiotix's SlimBiome Medical for the Gulf Cooperation Council States and the Levant.
O'Hara also recaps on a number of recent deals they've done including an agreement with Velinoff Pharma as well as the modified agreement with partner Sacco for its LPLDL cholesterol-lowering additive which has been extended out to 2023.
''These deals are all part of the next stage of the business cycle .... the focus now is on profitability''.